Werninghaus IC - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins.

Hinke DM, Anderson AM, Katta K, Laursen MF, Tesfaye DY, Werninghaus IC, Angeletti D, Grødeland G, Bogen B, Braathen R. Hinke DM, et al. Among authors: werninghaus ic. Nat Commun. 2024 Feb 12;15(1):850. doi: 10.1038/s41467-024-44889-w. Nat Commun. 2024. PMID: 38346952 Free PMC article.

Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.

Werninghaus IC, Hinke DM, Fossum E, Bogen B, Braathen R. Werninghaus IC, et al. Mol Ther. 2023 Jul 5;31(7):2188-2205. doi: 10.1016/j.ymthe.2023.03.012. Epub 2023 Mar 16. Mol Ther. 2023. PMID: 36926694 Free PMC article.

Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses.

Hinke DM, Andersen TK, Gopalakrishnan RP, Skullerud LM, Werninghaus IC, Grødeland G, Fossum E, Braathen R, Bogen B. Hinke DM, et al. Among authors: werninghaus ic. Cell Rep. 2022 May 31;39(9):110901. doi: 10.1016/j.celrep.2022.110901. Cell Rep. 2022. PMID: 35649357 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters